Computational Biology Market Key Findings by 2031
The Computational Biology Market is expected to register a CAGR of 13.4% from 2024 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Tools (Analysis Software and Services, Hardware, Databases); Application (Cellular and Biological Simulation, Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical Trials, Other Applications). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments
Purpose of the ReportThe report Computational Biology Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Computational Biology Market Segmentation
Tools- Analysis Software and Services
- Hardware
- Databases
- Cellular and Biological Simulation
- Drug Discovery and Disease Modelling
- Preclinical Drug Development
- Clinical Trials
- Other Applications
Strategic Insights
Computational Biology Market Growth Drivers- Explosion of Biological Data: The rapid increase in biological data, particularly from genomics, proteomics, and clinical studies, is a major driver for the market. This surge generates the demand for advanced computational tools for effective analysis and interpretation, further driving the demand for computational biology solutions.
- Increased Investment in Biotechnology:Investments into the biotechnology sector is growing. This investment is driven by the need for innovative solutions in drug development and personalized medicine, which contributes to the market growth.
- Cloud Computing: The adoption of cloud computing solutions is expected to increase, allowing researchers to access powerful computational resources without the need for extensive local infrastructure. This trend will facilitate collaboration and data sharing across institutions.
- Focus on Drug Discovery and Development: There will be an ongoing emphasis on using computational biology to modernize drug discovery and development processes. This includes optimizing lead compounds and predicting drug interactions, which can significantly reduce time and costs associated with bringing new drugs to market.
- Collaborations with Academic Institutions: Research and development that result from the collaboration between industry and academic institutions can be world-class. Such collaborations provide more to the practical implementation of computational biology in everyday applications.
- Expansion into New Markets: Expansion into emerging markets where the biotechnology and healthcare sectors are growing is feasible, now that computational biology tools are becoming increasingly available. Included in these are regions of Asia and Africa, where interest is gaining in using technology to advance health conditions.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Computational Biology Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Computational Biology Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Naveen
Naveen will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Some of the customization options available based on the request are an additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation#as our team would review the same and check the feasibility
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request
Cloud computing and focus on drug discovery and development are likely to remain a key trend in the market.
Explosion of biological data and increased investment in biotechnology are the major factors driving the computational biology market.
The Computational Biology Market is estimated to witness a CAGR of 13.4% from 2024 to 2031
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Computational Biology Market - By Tools
1.3.2 Computational Biology Market - By Application
1.3.3 Computational Biology Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. COMPUTATIONAL BIOLOGY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. COMPUTATIONAL BIOLOGY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. COMPUTATIONAL BIOLOGY MARKET - GLOBAL MARKET ANALYSIS
6.1. COMPUTATIONAL BIOLOGY - GLOBAL MARKET OVERVIEW
6.2. COMPUTATIONAL BIOLOGY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. COMPUTATIONAL BIOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - TOOLS
7.1. OVERVIEW
7.2. TOOLS MARKET FORECASTS AND ANALYSIS
7.3. ANALYSIS SOFTWARE AND SERVICES
7.3.1. Overview
7.3.2. Analysis Software and Services Market Forecast and Analysis
7.4. HARDWARE
7.4.1. Overview
7.4.2. Hardware Market Forecast and Analysis
7.5. DATABASES
7.5.1. Overview
7.5.2. Databases Market Forecast and Analysis
8. COMPUTATIONAL BIOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CELLULAR AND BIOLOGICAL SIMULATION
8.3.1. Overview
8.3.2. Cellular and Biological Simulation Market Forecast and Analysis
8.4. DRUG DISCOVERY AND DISEASE MODELLING
8.4.1. Overview
8.4.2. Drug Discovery and Disease Modelling Market Forecast and Analysis
8.5. PRECLINICAL DRUG DEVELOPMENT
8.5.1. Overview
8.5.2. Preclinical Drug Development Market Forecast and Analysis
8.6. CLINICAL TRIALS
8.6.1. Overview
8.6.2. Clinical Trials Market Forecast and Analysis
8.7. OTHER APPLICATIONS
8.7.1. Overview
8.7.2. Other Applications Market Forecast and Analysis
9. COMPUTATIONAL BIOLOGY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Computational Biology Market Overview
9.1.2 North America Computational Biology Market Forecasts and Analysis
9.1.3 North America Computational Biology Market Forecasts and Analysis - By Tools
9.1.4 North America Computational Biology Market Forecasts and Analysis - By Application
9.1.5 North America Computational Biology Market Forecasts and Analysis - By Countries
9.1.5.1 United States Computational Biology Market
9.1.5.1.1 United States Computational Biology Market by Tools
9.1.5.1.2 United States Computational Biology Market by Application
9.1.5.2 Canada Computational Biology Market
9.1.5.2.1 Canada Computational Biology Market by Tools
9.1.5.2.2 Canada Computational Biology Market by Application
9.1.5.3 Mexico Computational Biology Market
9.1.5.3.1 Mexico Computational Biology Market by Tools
9.1.5.3.2 Mexico Computational Biology Market by Application
9.2. EUROPE
9.2.1 Europe Computational Biology Market Overview
9.2.2 Europe Computational Biology Market Forecasts and Analysis
9.2.3 Europe Computational Biology Market Forecasts and Analysis - By Tools
9.2.4 Europe Computational Biology Market Forecasts and Analysis - By Application
9.2.5 Europe Computational Biology Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Computational Biology Market
9.2.5.1.1 Germany Computational Biology Market by Tools
9.2.5.1.2 Germany Computational Biology Market by Application
9.2.5.2 France Computational Biology Market
9.2.5.2.1 France Computational Biology Market by Tools
9.2.5.2.2 France Computational Biology Market by Application
9.2.5.3 Italy Computational Biology Market
9.2.5.3.1 Italy Computational Biology Market by Tools
9.2.5.3.2 Italy Computational Biology Market by Application
9.2.5.4 Spain Computational Biology Market
9.2.5.4.1 Spain Computational Biology Market by Tools
9.2.5.4.2 Spain Computational Biology Market by Application
9.2.5.5 United Kingdom Computational Biology Market
9.2.5.5.1 United Kingdom Computational Biology Market by Tools
9.2.5.5.2 United Kingdom Computational Biology Market by Application
9.2.5.6 Rest of Europe Computational Biology Market
9.2.5.6.1 Rest of Europe Computational Biology Market by Tools
9.2.5.6.2 Rest of Europe Computational Biology Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Computational Biology Market Overview
9.3.2 Asia-Pacific Computational Biology Market Forecasts and Analysis
9.3.3 Asia-Pacific Computational Biology Market Forecasts and Analysis - By Tools
9.3.4 Asia-Pacific Computational Biology Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Computational Biology Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Computational Biology Market
9.3.5.1.1 Australia Computational Biology Market by Tools
9.3.5.1.2 Australia Computational Biology Market by Application
9.3.5.2 China Computational Biology Market
9.3.5.2.1 China Computational Biology Market by Tools
9.3.5.2.2 China Computational Biology Market by Application
9.3.5.3 India Computational Biology Market
9.3.5.3.1 India Computational Biology Market by Tools
9.3.5.3.2 India Computational Biology Market by Application
9.3.5.4 Japan Computational Biology Market
9.3.5.4.1 Japan Computational Biology Market by Tools
9.3.5.4.2 Japan Computational Biology Market by Application
9.3.5.5 South Korea Computational Biology Market
9.3.5.5.1 South Korea Computational Biology Market by Tools
9.3.5.5.2 South Korea Computational Biology Market by Application
9.3.5.6 Rest of Asia-Pacific Computational Biology Market
9.3.5.6.1 Rest of Asia-Pacific Computational Biology Market by Tools
9.3.5.6.2 Rest of Asia-Pacific Computational Biology Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Computational Biology Market Overview
9.4.2 Middle East and Africa Computational Biology Market Forecasts and Analysis
9.4.3 Middle East and Africa Computational Biology Market Forecasts and Analysis - By Tools
9.4.4 Middle East and Africa Computational Biology Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Computational Biology Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Computational Biology Market
9.4.5.1.1 South Africa Computational Biology Market by Tools
9.4.5.1.2 South Africa Computational Biology Market by Application
9.4.5.2 Saudi Arabia Computational Biology Market
9.4.5.2.1 Saudi Arabia Computational Biology Market by Tools
9.4.5.2.2 Saudi Arabia Computational Biology Market by Application
9.4.5.3 U.A.E Computational Biology Market
9.4.5.3.1 U.A.E Computational Biology Market by Tools
9.4.5.3.2 U.A.E Computational Biology Market by Application
9.4.5.4 Rest of Middle East and Africa Computational Biology Market
9.4.5.4.1 Rest of Middle East and Africa Computational Biology Market by Tools
9.4.5.4.2 Rest of Middle East and Africa Computational Biology Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Computational Biology Market Overview
9.5.2 South and Central America Computational Biology Market Forecasts and Analysis
9.5.3 South and Central America Computational Biology Market Forecasts and Analysis - By Tools
9.5.4 South and Central America Computational Biology Market Forecasts and Analysis - By Application
9.5.5 South and Central America Computational Biology Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Computational Biology Market
9.5.5.1.1 Brazil Computational Biology Market by Tools
9.5.5.1.2 Brazil Computational Biology Market by Application
9.5.5.2 Argentina Computational Biology Market
9.5.5.2.1 Argentina Computational Biology Market by Tools
9.5.5.2.2 Argentina Computational Biology Market by Application
9.5.5.3 Rest of South and Central America Computational Biology Market
9.5.5.3.1 Rest of South and Central America Computational Biology Market by Tools
9.5.5.3.2 Rest of South and Central America Computational Biology Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. COMPUTATIONAL BIOLOGY MARKET, KEY COMPANY PROFILES
11.1. CHEMICAL COMPUTING GROUP ULC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. COMPUGEN
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. SIMULATION PLUS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GENEDATA AG
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CERTARA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. INSILICO BIOTECHNOLOGY AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ASTRAZENECA
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. FREENOME HOLDINGS, INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. GELTOR
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. NIMBUS THERAPEUTICS.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Chemical Computing Group ULC
2. Compugen
3. Simulation Plus
4. Genedata AG
5. Certara
6. Insilico Biotechnology AG
7. AstraZeneca
8. Freenome Holdings, Inc
9. GELTOR
10. Nimbus Therapeutics.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For